Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2013 by Sanquin Research & Blood Bank Divisions.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Maastricht University Medical Center
Atrium Medical Center
Radboud University
Orbis Medical Centre
Information provided by (Responsible Party):
Eva Rombout, Sanquin Research & Blood Bank Divisions
ClinicalTrials.gov Identifier:
NCT01398644
First received: July 19, 2011
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)